The invention relates to a medicament for preventing or treating human papilloma
virus (HPV)-specific tumors containing at least one fusion protein and optional
suitable additives and/or auxiliary agents. Said fusion protein is comprised of
at least one L1-protein of one or more papilloma viruses, and is also comprised
of at least one E-protein of one or more papilloma viruses, whereby the fusion
protein does not contain any papilloma virus non-specific epitopes.
